Sales decline 37.50% to Rs 0.05 crore
Net Loss of Transgene Biotek reported to Rs 5.17 crore in the quarter ended September 2016 as against net loss of Rs 4.59 crore during the previous quarter ended September 2015. Sales declined 37.50% to Rs 0.05 crore in the quarter ended September 2016 as against Rs 0.08 crore during the previous quarter ended September 2015. ParticularsQuarter EndedSep. 2016Sep. 2015% Var.Sales0.050.08 -38 OPM %-400.00-300.00 -PBDT-0.20-0.24 17 PBT-5.17-4.59 -13 NP-5.17-4.59 -13Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
